Pluto Bioinformatics

GSE92723: Transcriptome analysis for KDM6A mutated urothelial bladder carcinoma and EZH2 inhibitor treated KDM6A mutated urothelial bladder carcinoma

Bulk RNA sequencing

Purpose: The goals of this study are to compare 1. The transcription profile in KDM6A wildtype and KDM6A mutated urothelial bladder carcinoma. 2. The transcriptional changes in KDM6A mutated urothelial bladder carcinoma upon EZH2 inhibitor treatment. SOURCE: Xiaoran Chai (chaixiaoran1986@gmail.com) - DUKE-NUS